Dynavax Technologies | Caixa E Equivalentes





Caixa e Equivalentes Alterar Data
AbbVie USD 5.63B 838M 2025-09
Adma Biologics USD 61.38M 28.9M 2025-09
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Dynavax Technologies USD 160.25M 61.15M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
Glaxosmithkline GBP 3.3B 303M 2025-09
Merck USD 18.17B 10.16B 2025-09
Minerva Neurosciences USD 12.29M 2.96M 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neurocrine Biosciences USD 340.2M 76.2M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
TG Therapeutics USD 178.32M 100.54M 2025-09
Vertex Pharmaceuticals USD 6.29B 95.8M 2025-09


Dynavax Technologies Caixa E Equivalentes - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.